NAZEM FARZAD bought NAUT
June 18, 2026 · Form 4 insider transaction
NAZEM FARZAD bought 45,000 shares of Nautilus Biotechnology, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
45,000
Price
$0.00
Total value
N/A
InsiderNAZEM FARZAD
Role—
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateJune 18, 2026
Filing dateJune 22, 2026
Shares owned after45,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Subject to reporting person's continuous status as a "Service Provider" (as defined in the the Issuer's 2021 Equity Incentive Plan) through each applicable vesting date, one-twelfth (1/12th) of the shares subject to the Option shall vest on a monthly basis following the date of grant on the same day of the month as such grant date (or on the last day of the month, if there is no corresponding day in such month).